ImmunityBio, Inc.IBRXNASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank58
5Y CAGR-10.7%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-10.7%/yr
Long-term compound
Percentile
P58
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202531.07%
2024-24.09%
202339.21%
2022-22.72%
2021111.81%
202054.68%
2019-21.34%
2018-27.35%
2017-21.12%
2016-13.45%